These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31620732)

  • 41. Multi-functional core-shell Fe
    S R; M P
    Colloids Surf B Biointerfaces; 2019 Feb; 174():252-259. PubMed ID: 30469046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A bio-catalytically driven Janus mesoporous silica cluster motor with magnetic guidance.
    Ma X; Sanchez S
    Chem Commun (Camb); 2015 Mar; 51(25):5467-70. PubMed ID: 25407318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring of "on-demand" drug release using dual tumor marker mediated DNA-capped versatile mesoporous silica nanoparticles.
    Wang S; Liu F; Li XL
    Chem Commun (Camb); 2017 Aug; 53(62):8755-8758. PubMed ID: 28726871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioresponsive mesoporous silica nanoparticles for triggered drug release.
    Singh N; Karambelkar A; Gu L; Lin K; Miller JS; Chen CS; Sailor MJ; Bhatia SN
    J Am Chem Soc; 2011 Dec; 133(49):19582-5. PubMed ID: 21981330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hollow Mesoporous Silica@Metal-Organic Framework and Applications for pH-Responsive Drug Delivery.
    Jia X; Yang Z; Wang Y; Chen Y; Yuan H; Chen H; Xu X; Gao X; Liang Z; Sun Y; Li JR; Zheng H; Cao R
    ChemMedChem; 2018 Mar; 13(5):400-405. PubMed ID: 29337422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
    Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
    J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Luciferase and luciferin co-immobilized mesoporous silica nanoparticle materials for intracellular biocatalysis.
    Sun X; Zhao Y; Lin VS; Slowing II; Trewyn BG
    J Am Chem Soc; 2011 Nov; 133(46):18554-7. PubMed ID: 22007786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lectin-gated, mesoporous, photofunctionalized glyconanoparticles for glutathione-responsive drug delivery.
    Zhou J; Hao N; De Zoyza T; Yan M; Ramström O
    Chem Commun (Camb); 2015 Jun; 51(48):9833-6. PubMed ID: 25989158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
    Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
    J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioinspired polynorepinephrine nanoparticles as an efficient vehicle for enhanced drug delivery.
    Lu Z; Douek AM; Rozario AM; Tabor RF; Kaslin J; Follink B; Teo BM
    J Mater Chem B; 2020 Feb; 8(5):961-968. PubMed ID: 31922181
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mesoporous silica nanoparticles combining Au particles as glutathione and pH dual-sensitive nanocarriers for doxorubicin.
    Xu S; Li Y; Chen Z; Hou C; Chen T; Xu Z; Zhang X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():258-264. PubMed ID: 26652372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent.
    Guo R; Li LL; Zhao WH; Chen YX; Wang XZ; Fang CJ; Feng W; Zhang TL; Ma X; Lu M; Peng SQ; Yan CH
    Nanoscale; 2012 Jun; 4(11):3577-83. PubMed ID: 22543578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heterodimers made of metal-organic frameworks and upconversion nanoparticles for bioimaging and pH-responsive dual-drug delivery.
    Ling D; Li H; Xi W; Wang Z; Bednarkiewicz A; Dibaba ST; Shi L; Sun L
    J Mater Chem B; 2020 Feb; 8(6):1316-1325. PubMed ID: 31970370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Esterase- and pH-responsive poly(β-amino ester)-capped mesoporous silica nanoparticles for drug delivery.
    Fernando IR; Ferris DP; Frasconi M; Malin D; Strekalova E; Yilmaz MD; Ambrogio MW; Algaradah MM; Hong MP; Chen X; Nassar MS; Botros YY; Cryns VL; Stoddart JF
    Nanoscale; 2015 Apr; 7(16):7178-83. PubMed ID: 25820516
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies on interaction potency model based on drug synergy and therapeutic potential of triple stimuli-responsive delivery of doxorubicin and 5-fluoro-2-deoxyuridine against lymphoma using disulfide-bridged cysteine over mesoporous silica nanoparticles.
    Srivastava P; Hira SK; Paladhi A; Singh R; Gupta U; Srivastava DN; Singh RA; Manna PP
    J Mater Chem B; 2020 Feb; 8(7):1411-1421. PubMed ID: 31974541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enzyme-Induced Transformable Peptide Nanocarriers with Enhanced Drug Permeability and Retention to Improve Tumor Nanotherapy Efficacy.
    Gong Z; Zhou B; Liu X; Cao J; Hong Z; Wang J; Sun X; Yuan X; Tan H; Ji H; Bai J
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55913-55927. PubMed ID: 34784165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biocompatible Au@Ag nanorod@ZIF-8 core-shell nanoparticles for surface-enhanced Raman scattering imaging and drug delivery.
    Jiang P; Hu Y; Li G
    Talanta; 2019 Aug; 200():212-217. PubMed ID: 31036175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Janus Silver-Mesoporous Silica Nanocarriers for SERS Traceable and pH-Sensitive Drug Delivery in Cancer Therapy.
    Shao D; Zhang X; Liu W; Zhang F; Zheng X; Qiao P; Li J; Dong WF; Chen L
    ACS Appl Mater Interfaces; 2016 Feb; 8(7):4303-8. PubMed ID: 26844695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.